PLYMOUTH
MEETING, Pa., Feb. 28,
2024 /PRNewswire/ -- Harmony Biosciences
Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's
management team will participate in the following upcoming investor
conferences:
Leerink Partners Global Biopharma Conference 2024
- Location: Miami
- Fireside Chat: Monday, March 11,
2024, at 12:40 p.m. ET
Barclays 26th Annual Global Healthcare Conference
- Location: Miami
- Fireside Chat: Tuesday, March 12,
2024, at 3:35 p.m. ET
A webcast of the fireside chats will be available on the
investor page of Harmony's website at
https://ir.harmonybiosciences.com/.
About Harmony Biosciences
At Harmony Biosciences, we specialize in developing and
delivering treatments for rare neurological diseases that others
often overlook. We believe that where empathy and innovation meet,
a better life can begin for people living with neurological
diseases. Established by Paragon Biosciences, LLC, in 2017 and
headquartered in Plymouth Meeting, PA, our team of experts
from a wide variety of disciplines and experiences is driven by our
shared conviction that innovative science translates into
therapeutic possibilities for our patients, who are at the heart of
everything we do. For more information, please
visit www.harmonybiosciences.com.
Harmony Biosciences Investor Contact:
Luis Sanay, CFA
445-235-8386
lsanay@harmonybiosciences.com
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-upcoming-investor-conferences-302073404.html
SOURCE Harmony Biosciences